Rosemary Szparagowski

Rosemary Szparagowski practices at Cnp Operating Co in Blue Ash, Ohio.

Rosemary Szparagowski's NPI, 1962856815, was assigned on April 18, 2016. Rosemary Szparagowski holds Ohio license 35133622.

Rosemary Szparagowski's primary practice is Cnp Operating Co, at 10123 Alliance Rd, Blue Ash, OH 45242 in Hamilton County. The practice phone is (410) 749-2474.

Rosemary Szparagowski's primary practice is Cnp Operating Co in Blue Ash, Ohio. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Rosemary Szparagowski to 3 more medical groups, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rosemary Szparagowski practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Rosemary Szparagowski's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Rosemary Szparagowski is licensed in Ohio.

CMS data shows 182 Medicare services from Rosemary Szparagowski across 4 procedure codes in 2024, for 61 Medicare patients. Medicare paid $14,017 for them.

CMS counts 61 Medicare patients who saw Rosemary Szparagowski in 2024. The largest group is under 65, with 25 patients. 75% of them have anxiety, and 75% have high blood pressure. 75% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rosemary Szparagowski's median patient age at 69, with 47% women.

In 2024, Rosemary Szparagowski wrote 470 Medicare Part D claims for 88 patients. 92% of them were for generic drugs. CMS names the drug for 323 of them, across 11 drugs with 11 or more claims each, at $30,411 in total drug cost. In 2021, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Rosemary Szparagowski for performance year 2024, reported as part of a group. Rosemary Szparagowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rosemary Szparagowski as offering telehealth.

CMS Open Payments shows 4 general payments to Rosemary Szparagowski from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $53.